-
Other
-
Resolution: Delivered
-
Minor
-
None
Dont know if this is correct to submit here but I submitted the following ? to QNET and they referred me to your website. Here is the ?.....This is a very broad question. I am working with an internal MU2 group. The consensus is that once IQR vte core measure set is electronically submitted, it will adopt MU guidelines. The group is in the process of looking at how orders should go into EPIC. There is a "reason for no VTE" order that we use currently and if a pt. does not have VTE ppx on HD 0 or 1 according to MU, if that order is on the chart it is enough to pass the measure VTE-1. THere are also available in Epic orders that read "reason for no VTE ppx-pharmacologic" and "reason for no VTE ppx-mechanical". My IQR hat says we should have those two orders because in the IQR world you need a reason for both mech and pharm. ppx not given if pt did not receive ppx on day 0 or 1 (and they are high risk).
The broad question is
1) when IQR VTE set is submitted via emeasure is it going to follow MU guidelines?
2) when IQR VTE is emeasure is it going to follow IQR current guidelines?
3) Are we going to have to distinguish between the two- MU/IQR?
Again the consensus is we will submit MU and that covers our requirements for IQR as well even though there are differences in the guidelines. I would like to see us build up front the necessary orders instead of waiting until the 11th hour and then need to scramble and put orders in to meet IQR requirements. For whatever reason, I just cannot seem to understand how MU and IQR VTE sets are going to align with current guidelines? Before I spend lots of time and effort trying to convince people to include IQR VTE type orders and documentation up front, it would be nice to know if IQR VTE emeasure submission is going to disregard the current IQR guidelines and adopt MU which are less strict than IQR for the most part?